Endomyocardial nitric oxide synthase and left ventricular preload reserve in dilated cardiomyopathy.
- 15 June 1999
- journal article
- other
- Published by Wolters Kluwer Health in Circulation
- Vol. 99 (23) , 3009-3016
- https://doi.org/10.1161/01.cir.99.23.3009
Abstract
Background —Patients with heart failure have modified myocardial expression of nitric oxide synthase (NOS), as is evident from induction of calcium-insensitive NOS isoforms. The functional significance of this modified NOS gene expression for left ventricular (LV) contractile performance was investigated in patients with dilated nonischemic cardiomyopathy. Methods and Results —In patients with dilated, nonischemic cardiomyopathy, invasive measures of LV contractile performance were derived from LV microtip pressure recordings and angiograms and correlated with intensity of gene expression of inducible (NOS2) and constitutive (NOS3) NOS isoforms in simultaneously procured LV endomyocardial biopsies (n=20). LV endomyocardial expression of NOS2 was linearly correlated with LV stroke volume ( P =0.001; r =0.66), LV ejection fraction ( P =0.007; r =0.58), and LV stroke work ( P =0.003; r =0.62). In patients with elevated LV end-diastolic pressure (>16 mm Hg), a closer correlation was observed between endomyocardial expression of NOS2 and LV stroke volume ( P =0.001; r =0.74), LV ejection fraction ( P =0.0007; r =0.77), and LV stroke work ( r =0.82; P =0.0002). LV endomyocardial expression of NOS3 was linearly correlated with LV stroke volume ( P =0.01; r =0.53) and LV stroke work ( P =0.01; r =0.52). To establish the role of nitric oxide (NO) as a mediator of the observed correlations, substance P (which causes endothelial release of NO) was infused intracoronarily (n=12). In patients with elevated LV end-diastolic pressure, an intracoronary infusion of substance P increased LV stroke volume from 72±13 to 91±16 mL ( P =0.06) and LV stroke work from 67±11 to 90±15 g · m ( P =0.03) and shifted the LV end-diastolic pressure–volume relation to the right. Conclusions —In patients with dilated cardiomyopathy, an increase in endomyocardial NOS2 or NOS3 gene expression augments LV stroke volume and LV stroke work because of a NO-mediated rightward shift of the diastolic LV pressure-volume relation and a concomitant increase in LV preload reserve.Keywords
This publication has 8 references indexed in Scilit:
- Increased expression of constitutive nitric oxide synthase III, but not inducible nitric oxide synthase II, in human heart failure 11During publication process the following related paper has been published by Vejlstrup NG, Bouloumie A, Boesgaard S, Andersen CB, Nielsen-Kudsk JE, Mortensen SA, Kent JD, Harrison DG, Busse R, Alsershvile J. Inducible nitric oxide synthase (iNOS) in the human heart: Expression and localization in congestive heart failure. J Mol Cell Cardiol 1998;30:1215–23.Journal of the American College of Cardiology, 1998
- Expression, activity and functional significance of inducible nitric oxide synthase in the failing human heartJournal of the American College of Cardiology, 1998
- Regulation by cAMP of Post-translational Processing and Subcellular Targeting of Endothelial Nitric-oxide Synthase (Type 3) in Cardiac MyocytesJournal of Biological Chemistry, 1997
- Inducible Nitric Oxide Synthase and Tumor Necrosis Factor-Alpha in Myocardium in Human Dilated CardiomyopathyJournal of the American College of Cardiology, 1997
- Nitric oxide synthase (NOS3) and contractile responsiveness to adrenergic and cholinergic agonists in the heart. Regulation of NOS3 transcription in vitro and in vivo by cyclic adenosine monophosphate in rat cardiac myocytes.Journal of Clinical Investigation, 1996
- Expression of Inducible Nitric Oxide Synthase in Human Heart FailureCirculation, 1996
- Increased production of nitric oxide in coronary arteries during congestive heart failure.Journal of Clinical Investigation, 1994
- Nitric oxide synthase activities in human myocardiumThe Lancet, 1993